Literature DB >> 14759798

Sleeping beauty transposition: biology and applications for molecular therapy.

Zsuzsanna Izsvák1, Zoltán Ivics.   

Abstract

Transposable elements can be considered as natural, nonviral gene-delivery vehicles and are valuable and widely used tools for germ-line transgenesis and insertional mutagenesis in invertebrate systems such as flies and worms. Such tools were not available for genome manipulations in vertebrates until recently, when an active element was resurrected from transposon fossils found in fish genomes. This element, the Sleeping Beauty transposon, shows efficient transposition in cells of a wide range of vertebrates, including humans. Sleeping Beauty transposition is a cut-and-paste process, during which the element "jumps" from one DNA molecule to another. Transposon integration into chromosomes provides the basis for long-term, or possibly permanent, transgene expression in transgenic cells and organisms. Thus, the reconstruction of the Sleeping Beauty element generated considerable interest in developing efficient and safe vectors for vertebrate transgenesis as well as for human gene therapy. In this review we summarize our current knowledge of Sleeping Beauty biology and describe the strengths and current limitations of transposon technology for gene therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14759798     DOI: 10.1016/j.ymthe.2003.11.009

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  72 in total

1.  Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells.

Authors:  Stephen R Yant; Julie Park; Yong Huang; Jacob Giehm Mikkelsen; Mark A Kay
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 2.  Transposon-mediated adaptive and directed mutations and their potential evolutionary benefits.

Authors:  Zhongge Zhang; Milton H Saier
Journal:  J Mol Microbiol Biotechnol       Date:  2012-01-13

3.  Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells.

Authors:  Xin Huang; Kari Haley; Marianna Wong; Hongfeng Guo; Changming Lu; Andrew Wilber; Xianzheng Zhou
Journal:  Hum Gene Ther       Date:  2010-10-19       Impact factor: 5.695

4.  High-resolution genome-wide mapping of transposon integration in mammals.

Authors:  Stephen R Yant; Xiaolin Wu; Yong Huang; Brian Garrison; Shawn M Burgess; Mark A Kay
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 5.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

6.  Integrating DNA vectors for gene therapy.

Authors:  Perry B Hackett
Journal:  Mol Ther       Date:  2007-01       Impact factor: 11.454

Review 7.  Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy.

Authors:  Ethlinn V B van Gaal; Wim E Hennink; Daan J A Crommelin; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

8.  piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells.

Authors:  Sareina Chiung-Yuan Wu; Yaa-Jyuhn James Meir; Craig J Coates; Alfred M Handler; Pawel Pelczar; Stefan Moisyadi; Joseph M Kaminski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-27       Impact factor: 11.205

Review 9.  Current advances and future challenges in Adenoviral vector biology and targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Curr Gene Ther       Date:  2007-06       Impact factor: 4.391

Review 10.  A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19.

Authors:  Harjeet Singh; Helen Huls; Partow Kebriaei; Laurence J N Cooper
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.